Examining the Effects of CXB722 in Neuroendocrine Stress Response in Healthy Males (CXB722-100)
This study has been completed.
Sponsor:
CeNeRx BioPharma Inc.
Information provided by:
National Institute on Aging (NIA)
ClinicalTrials.gov Identifier:
NCT00814931
First received: December 23, 2008
Last updated: January 9, 2009
Last verified: January 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | December 2008 |
| Primary Completion Date: | December 2008 (Final data collection date for primary outcome measure) |